Dimethyl Fumarate (Tecfidera): A New Oral Agent for Multiple Sclerosis (vol 47, pg 1697, 2013)

被引：0
|
作者：
Venci, J. V.
Gandhi, M. A.
机构：
来源：
ANNALS OF PHARMACOTHERAPY | 2014年 / 48卷 / 05期
关键词：
D O I：
10.1177/1060028014529923
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：668 / 668
页数：1
相关论文
共 50 条
  • [21] Advances in the management of relapsing-remitting multiple sclerosis: role of oral dimethyl fumarate (BG-12)
    Nielsen, A. Scott
    DEGENERATIVE NEUROLOGICAL AND NEUROMUSCULAR DISEASE, 2015, 5
  • [22] Remyelination following oral administration of dimethyl fumarate in the Theiler's murine encephalomyelitis virus model of multiple sclerosis
    Carlson, N. G.
    Schmidt, L. A.
    Wood, B.
    Clendennon, C.
    Weber, L. M.
    Soldan, M. M. Paz
    Rose, J. W.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 622 - 622
  • [23] Oral BG-12 (dimethyl fumarate) for relapsing-remitting multiple sclerosis: a review of DEFINE and CONFIRM
    Havrdova, Eva
    Hutchinson, Michael
    Kurukulasuriya, Nuwan C.
    Raghupathi, Kartik
    Sweetser, Marianne T.
    Dawson, Katherine T.
    Gold, Ralf
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (15) : 2145 - 2156
  • [24] Sexual dysfunction in patients with multiple sclerosis (vol 2, pg 117, 2013)
    Orasanu, Bogdan
    Frasure, Heidi
    Wyman, Allison
    Mahajan, Sangeeta T.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2013, 2 (03) : 259 - 259
  • [25] Dimethyl fumarate treatment mediates an anti-inflammatory shift in B cell subsets of patients with multiple sclerosis (vol 198, pg 691, 2017)
    Li, R.
    Rezk, A.
    Ghadiri, M.
    Luessi, F.
    Zipp, F.
    Li, H.
    Giacomini, P. S.
    Antel, J.
    Bar-Or, A.
    JOURNAL OF IMMUNOLOGY, 2019, 202 (07): : 2172 - 2172
  • [26] Epidemiology in multiple sclerosis: a pilgrim's progress (vol 136, pg 2904, 2013)
    Kurtzke, John F.
    BRAIN, 2014, 137
  • [27] Spasticity in multiple sclerosis: results of a patient survey (vol 123, pg 400, 2013)
    Oreja-Guevara, C.
    INTERNATIONAL JOURNAL OF NEUROSCIENCE, 2013, 123 (10) : 743 - 743
  • [28] The case for vitamin D supplementation in multiple sclerosis (vol 2, pg 281, 2013)
    Ganesh, Aravind
    Apel, Sabrina
    Metz, Luanne
    Patten, Scott
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2014, 3 (05) : 666 - 666
  • [29] A propensity-matched comparison of long-term disability worsening in patients with multiple sclerosis treated with dimethyl fumarate or fingolimod (vol 14, pg 1, 2021)
    Salter, Amber
    Lancia, Samantha
    Cutter, Gary
    Marrie, Ruth Ann
    Lewin, James B.
    Fox, Robert J.
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2021, 14
  • [30] The New Oral Anticoagulants in Clinical Practice (vol 88, pg 495, 2013)
    Gonsalves, W., I
    MAYO CLINIC PROCEEDINGS, 2013, 88 (07) : 777 - 777
12345